Investor Revolts Against CoreWeave's Critical $5 Billion Acquisition

The potential acquisition of Core Scientific by CoreWeave, a giant in cloud computing AI, is facing rising opposition ahead of a crucial shareholder meeting. Trip Miller, who leads the investment firm Gullane Capital, voiced his intention to vote against the deal, emphasizing that the current financial arrangements depreciate the investment value in Core Scientific. Gullane Capital holds a substantial investment in the corporation, trailing only Vanguard and BlackRock as Core Scientific's largest shareholders, with a worth approximating $200 million.

Miller's disapproval adds to a wave of shareholder dissatisfaction, raising concerns about one of the most significant mergers in the data center sector this fiscal year. CoreWeave aims for this $5 billion acquisition to bolster rapid growth and mitigate its increasing cost burdens. However, market fluctuations—marked by a dip in CoreWeave's stock value—have sparked apprehensions that the offer inadequately compensates for Core Scientific's worth, especially as the shareholder vote looms.

Two Seas Capital, another prominent investment entity possessing about 6.3% of Core Scientific's shares, delivered an extensive critique via a presentation released on October 14. The firm leveled multiple objections, asserting that the merger doesn't sufficiently benefit shareholders financially. The presentation urged stockholders to reject the deal in the impending vote scheduled for October 30.

In defense, Michael Intrator, CoreWeave's CEO, proclaimed the necessity of the buyout for unlocking substantial future advantages for both sets of stockholders. He stressed that the current deal represents the final and most advantageous proposal. Quoting his letter dated October 16, Intrator dismissed the criticisms from Two Seas Capital as both inaccurate and misleading.

Strategic Growth Versus Burgeoning Expenses

Since launching its IPO shakily in March, CoreWeave has soared to a market valuation of $70 billion, making substantial strides within the burgeoning data center industry. This ascent has been fueled by high-profile contracts with tech giants like OpenAI, Meta, Microsoft, and Nvidia. CoreWeave's acquisition spree includes AI development companies and cloud service providers to enhance its expansive customer offerings.

During a second-quarter earnings discussion, Intrator articulated the expansive scale required by their primary clients for infrastructure development, which includes vast data centers. The company's aggressive growth strategy is evident in its objective to escalate its data center capacity from 470 to over 900 megawatts by 2025, equating to about 20% of daily power usage in New York City. The acquisition of Core Scientific could double this capacity, significantly boosting CoreWeave's energy capabilities by 50%, amassing to a total of over 3 gigawatts.

Despite this promising expansion, revenue metrics reveal a complex scenario. CoreWeave reported Q2 revenue exceeding $1.2 billion—over twice the figures from last year during the same timeframe—underscoring a lucrative outlook. However, operating margins tumbled from 20% to a mere 2% annually, highlighting how rising expenses are chipping away at profits.

Compounding these challenges, CoreWeave's debt swelled to $11.2 billion by Q2's close, climbing by 40% relative to early-year figures, with loan interest ranging from 7% to 15%. Financial analyst Gil Luria has spotlighted the financial strain such borrowing imposes—a stark contrast to the company's relatively slim margins.

Acquiring Core Scientific represents an opportunity for easing overhead pressures. Currently, CoreWeave leases approximately 270 megawatts in data center space from Core Scientific. Owning this space outright could save an estimated $10 billion in leasing fees over the upcoming 12 years.

Reevaluation of Market Worth in Data Centers

Market shifts have complicated the proposed merger's economics, with CoreWeave's share value declining while Core Scientific's has climbed. Presently, the merger pegs Core Scientific shares at around $17, trailing the market value of roughly $19. CoreWeave and Core Scientific adhered to media requests for comments on these developments.

Two Seas Capital flagged the transaction's economics, contending it fails to shield shareholders from stock volatility that disrupts deal valuations. They assert the initial headline offer of $20.40 per share undervalued Core Scientific, particularly after CoreWeave's share price later plummeted, making the acquisition seem more like a devaluation of Core Scientific rather than a merger.

CEO Intrator, in a subsequent letter, highlighted that CoreWeave represents the primary customer base for Core Scientific's data centers, comprising 76% of their revenue. He urged shareholders to weigh the substantial risks of retaining independence against the merger's strategic advantages.

Conversely, Miller argued that in today's hot data center market, allowing Core Scientific to operate independently for an additional 18 months could potentially elevate its stock valuation to between $30 to $40 per share, positioning it as a more appealing acquisition target.